Martin Shkreli’s Former Company Ordered to Pay $40 Million in Settlement Over Price-Gouging Case

  • 📰 WSJ
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

A drug company formerly run by Martin Shkreli was ordered to pay up to $40 million to settle allegations that it substantially raised prices of lifesaving medication

, the Federal Trade Commission said.

Vyera Pharmaceuticals LLC, which Mr. Shkreli ran as chief executive when it was called Turing Pharmaceuticals AG, purchased exclusive rights to antiparasitic drug Daraprim for $55 million in 2015 and raised the price of the drug to $750 per tablet from $17.50 a tablet, while preventing competitors from producing generic versions of it, according to court documents. The increase

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

40 MiLliOn. Big fucking deal.

Wheels of justice are slow 😬

Pharma Bro 😎 Numero Uno. Does anyone remember when he wanted to buy the Wu Tang Clan rap album for his exclusive use? Whatever happened with that?

How much did he make. Again So corp merica acts out and steals , gobt says bad boi u owe us 2% back

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 98. in SA

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين